Federal Register #DEA-1795

DEA notice on Diamond Animal Health’s application to import pentobarbital

This is a DEA regulatory notice about Diamond Animal Health, Inc.’s proposed importation of pentobarbital, not a procurement solicitation. - Government buyer: U.S. Department of Justice, Drug Enforcement Administration (DEA); no purchasing office is identified. - Company and product: Diamond Animal Health, Inc. plans to import pentobarbital (drug code 2270, Schedule II) for use in manufacturing Euthasol, a Schedule III (N) finished dosage form. - Scope limitation: The proposed registration would not authorize other activities involving the drug code or importation of finished dosage forms for commercial sale. - Procurement details: No products or services are being solicited for purchase, and no quantities, part numbers, or contract value are provided.

Description

Diamond Animal Health, Inc. applied to the Drug Enforcement Administration to register as an importer of controlled substances. The company plans to import pentobarbital to support manufacture of the Schedule III (N) finished dosage form Euthasol. No other activity for this drug code is authorized under the registration. Comments, objections, and hearing requests are due by December 7, 2026.

View original listing